{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:15:32Z","timestamp":1793146532793,"version":"4.5.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2008,4,16]],"date-time":"2008-04-16T00:00:00Z","timestamp":1208304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,5,6]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Wheat gliadin induces severe intestinal symptoms and small-bowel mucosal damage in coeliac disease patients. At present, the only effective treatment for the disease is a strict life-long gluten-free diet. In this study we investigated whether probiotics Lactobacillus fermentum or Bifidobacterium lactis can inhibit the toxic effects of gliadin in intestinal cell culture conditions. The ability of live probiotics to inhibit peptic-tryptic digested gliadin-induced damage to human colon cells Caco-2 was evaluated by measuring epithelial permeability by transepithelial resistance, actin cytoskeleton arrangements by the extent of membrane ruffling and expression of tight junctional protein ZO-1. B. lactis inhibited the gliadin-induced increase dose-dependently in epithelial permeability, higher concentrations completely abolishing the gliadin-induced decrease in transepithelial resistance. The same bacterial strain also inhibited the formation of membrane ruffles in Caco-2 cells induced by gliadin administration. Furthermore, it also protected the tight junctions of Caco-2 cells against the effects of gliadin, as evinced by the pattern of ZO-1 expression. We conclude thus that live B. lactis bacteria can counteract directly the harmful effects exerted by coeliac-toxic gliadin and would clearly warrant further studies of its potential as a novel dietary supplement in the treatment of coeliac disease.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2008.03635.x","type":"journal-article","created":{"date-parts":[[2010,7,27]],"date-time":"2010-07-27T10:35:37Z","timestamp":1280226937000},"page":"552-558","source":"Crossref","is-referenced-by-count":174,"title":["Live probiotic<i>Bifidobacterium lactis<\/i>bacteria inhibit the toxic effects induced by wheat gliadin in epithelial cell culture"],"prefix":"10.1093","volume":"152","author":[{"given":"K","family":"Lindfors","sequence":"first","affiliation":[{"name":"Paediatric Research Centre, Medical School, University of Tampere, Department of Peadiatrics, Tampere University Hospital, Tampere, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Blomqvist","sequence":"additional","affiliation":[{"name":"Paediatric Research Centre, Medical School, University of Tampere, Department of Peadiatrics, Tampere University Hospital, Tampere, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Juuti-Uusitalo","sequence":"additional","affiliation":[{"name":"Paediatric Research Centre, Medical School, University of Tampere, Department of Peadiatrics, Tampere University Hospital, Tampere, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Stenman","sequence":"additional","affiliation":[{"name":"Paediatric Research Centre, Medical School, University of Tampere, Department of Peadiatrics, Tampere University Hospital, Tampere, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Ven\u00e4l\u00e4inen","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, University of Kuopio, Kuopio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"M\u00e4ki","sequence":"additional","affiliation":[{"name":"Paediatric Research Centre, Medical School, University of Tampere, Department of Peadiatrics, Tampere University Hospital, Tampere, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Kaukinen","sequence":"additional","affiliation":[{"name":"Medical School, University of Tampere, Finland and Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital, Tampere, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2008,4,16]]},"reference":[{"key":"2022010405185886700_b1","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/01.meg.0000221847.09792.34","article-title":"Gliadin, glutenin or both? The search for the Holy grail in celiac disease","volume":"18","author":"Howdle","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2022010405185886700_b2","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00042737-200605000-00005","article-title":"The toxicity of high molecular weight glutenin subunits of wheat to patients with celiac disease","volume":"18","author":"Dewar","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2022010405185886700_b3","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1126\/science.1074129","article-title":"Structural basis for gluten intolerance in celiac sprue","volume":"297","author":"Shan","year":"2002","journal-title":"Science"},{"key":"2022010405185886700_b4","doi-asserted-by":"crossref","first-page":"G996","DOI":"10.1152\/ajpgi.00136.2002","article-title":"Intestinal digestive resistance of immunodominant gliadin peptides","volume":"283","author":"Hausch","year":"2002","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2022010405185886700_b5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2005.09.015","article-title":"Is celiac disease an autoimmune disorder?","volume":"17","author":"Sollid","year":"2005","journal-title":"Curr Opin Immunol"},{"key":"2022010405185886700_b6","first-page":"1","article-title":"Genetic background of celiac disease and its clinical implications","volume":"102","author":"Wolters","year":"2007","journal-title":"J Gastroenterol"},{"key":"2022010405185886700_b7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0140-6736(03)13803-2","article-title":"Association between innate response to gliadin and activation of pathogenic T cells in celiac disease","volume":"62","author":"Maiuri","year":"2003","journal-title":"Lancet"},{"key":"2022010405185886700_b8","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1189\/jlb.71.4.625","article-title":"Activation of macrophages by gliadin fragments: isolation and characterization of active peptide","volume":"71","author":"Tuckova","year":"2002","journal-title":"J Leukoc Biol"},{"key":"2022010405185886700_b9","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.4049\/jimmunol.173.3.1925","article-title":"Wheat gluten causes dendritic cell maturation and chemokine secretion","volume":"173","author":"Nikulina","year":"2004","journal-title":"J Immunol"},{"key":"2022010405185886700_b10","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.immuni.2004.06.018","article-title":"A direct role for NKG2D\/MICA interaction in villous atrophy during celiac disease","volume":"21","author":"Hue","year":"2004","journal-title":"Immunity"},{"key":"2022010405185886700_b11","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/ncpgasthep0111","article-title":"Future therapeutic options for celiac disease","volume":"2","author":"Sollid","year":"2005","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"2022010405185886700_b12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/gut.2006.111609","article-title":"Efficient degradation of gluten by a prolyl endopeptidase in a gastrointestinal model: implications for celiac disease","volume":"57","author":"Mitea","year":"2008","journal-title":"Gut"},{"key":"2022010405185886700_b13","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1053\/j.gastro.2007.05.028","article-title":"Combination enzyme therapy for gastric digestion of dietary gluten in patients with celiac sprue","volume":"133","author":"Gass","year":"2007","journal-title":"Gastroenterology"},{"key":"2022010405185886700_b14","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/j.1365-2672.2005.02730.x","article-title":"Proteolytic activity and reduction of gliadin-like fractions by sourdough lactobacilli","volume":"99","author":"Rollan","year":"2005","journal-title":"J Appl Microbiol"},{"key":"2022010405185886700_b15","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1128\/AEM.68.2.623-633.2002","article-title":"Proteolysis by sourdough lactic acid bacteria: effects on wheat flour protein fractions and gliadin peptides involved in human cereal intolerance","volume":"68","author":"Di Cagno","year":"2002","journal-title":"Appl Environ Microbiol"},{"key":"2022010405185886700_b16","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1128\/AEM.70.2.1088-1096.2004","article-title":"Sourdough bread made from wheat and nontoxic flours and strated with selected lactobacilli is tolerated in celiac sprue patients","volume":"70","author":"Di Cagno","year":"2004","journal-title":"Appl Environ Microbiol"},{"key":"2022010405185886700_b17","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1472-765X.2006.01889.x","article-title":"Gluten breakdown by lactobacilli and pediococci strains isolated from sourdough","volume":"42","author":"Gerez","year":"2006","journal-title":"Lett Appl Microbiol"},{"key":"2022010405185886700_b18","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1128\/AEM.00260-07","article-title":"Highly efficient gluten degradation by lactobacilli and fungal proteases during food processing: new perspectives for celiac disease","volume":"73","author":"Rizzello","year":"2007","journal-title":"Appl Environ Microbiol"},{"key":"2022010405185886700_b19","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1016\/j.febslet.2005.07.066","article-title":"Rapid distruption of intestinal barrier function by gliadin involves altered expression of apical junctional proteins","volume":"579","author":"Sander","year":"2005","journal-title":"FEBS Lett"},{"key":"2022010405185886700_b20","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1053\/j.gastro.2005.07.054","article-title":"Unexpected role of surface transglutaminase type II in celiac disease","volume":"129","author":"Maiuri","year":"2005","journal-title":"Gastroenterology"},{"key":"2022010405185886700_b21","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/gut.2005.086637","article-title":"Growth factor-like activity of gliadin, an alimentary protein: implications for celiac disease (CD)","volume":"56","author":"Barone","year":"2007","journal-title":"Gut"},{"key":"2022010405185886700_b22","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1021\/bi00676a011","article-title":"Glutamine supports recovery from loss of transepithelial resistance and increase of permeability induced by media change in Caco-2 cells","volume":"14","author":"Li","year":"2003","journal-title":"J Nutr Biochem"},{"key":"2022010405185886700_b23","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1021\/jf052504s","article-title":"Proteolysis in model sourdough fermentation","volume":"54","author":"Zotta","year":"2006","journal-title":"J Agric Food Chem"},{"key":"2022010405185886700_b24","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bbadis.2005.09.008","article-title":"VSL3# probiotic preparation has the capacity to hydrolyse gliadin polypeptides responsible for celiac sprue","volume":"1762","author":"De Angelis","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"2022010405185886700_b25","doi-asserted-by":"crossref","first-page":"G613","DOI":"10.1152\/ajpgi.00341.2003","article-title":"Functional modulation of enterocytes by Gram-positive and Gram-negative microorganisms","volume":"286","author":"Otte","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2022010405185886700_b26","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/ptr.1772","article-title":"Assessment of a bioactive compound for its potential anti-inflammatory property by tight junction permeability","volume":"19","author":"Bai","year":"2005","journal-title":"Phytoter Res"},{"key":"2022010405185886700_b27","doi-asserted-by":"crossref","first-page":"7528","DOI":"10.1128\/AEM.71.11.7528-7530.2005","article-title":"Application of measurement of transepithelial electrical resistance of intestinal epithelial cell monolayers to evaluate probiotic activity","volume":"71","author":"Klingberg","year":"2005","journal-title":"Appl Environ Microbiol"},{"key":"2022010405185886700_b28","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/gut.52.7.988","article-title":"Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC)","volume":"52","author":"Resta-Lenert","year":"2003","journal-title":"Gut"},{"key":"2022010405185886700_b29","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1177\/039463200601900407","article-title":"Effect of Bifidobacterium infantis on interferon-gamma-induced keratinocyte apoptosis: a potential therapeutic approach to skin immune abnormalities","volume":"19","author":"Cinque","year":"2006","journal-title":"Int J Immunopathol Pharmacol"},{"key":"2022010405185886700_b30","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1053\/j.gastro.2006.11.022","article-title":"Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth","volume":"132","author":"Yan","year":"2007","journal-title":"Gastroenterology"},{"key":"2022010405185886700_b31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1207\/s15327914nc5101_12","article-title":"Bifidobacterium lactis sp420 up-regulates cyclooxygenase (Cox)-1 and downregulates Cox-2 gene expression in a Caco-2 cell culture model","volume":"51","author":"Nurmi","year":"2005","journal-title":"Nutr Cancer"},{"key":"2022010405185886700_b32","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.2174\/138161207780831293","article-title":"COX-2: friend or foe?","volume":"13","author":"Iezzi","year":"2007","journal-title":"Curr Pharm Des"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2008.03635.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2008.03635.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/152\/3\/552\/42045178\/j.1365-2249.2008.03635.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/152\/3\/552\/42045178\/j.1365-2249.2008.03635.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T10:40:16Z","timestamp":1685702416000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/152\/3\/552\/6457583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,16]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2008,4,16]]},"published-print":{"date-parts":[[2008,5,6]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2008.03635.x","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2008,6]]},"published":{"date-parts":[[2008,4,16]]}}}